In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms

BACKGROUND: Rifabutin, an oral drug approved to treat Mycobacterium avium infections, demonstrated potent activity against Acinetobacter baumannii in nutrient-limited medium enabled by rifabutin cellular uptake through the siderophore receptor FhuE. OBJECTIVES: To determine rifabutin in vitro activi...

詳細記述

保存先:
書誌詳細
出版年:J Antimicrob Chemother
主要な著者: Trebosc, Vincent, Schellhorn, Birgit, Schill, Julian, Lucchini, Valentina, Bühler, Jacqueline, Bourotte, Marilyne, Butcher, Jonathan J, Gitzinger, Marc, Lociuro, Sergio, Kemmer, Christian, Dale, Glenn E
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662187/
https://ncbi.nlm.nih.gov/pubmed/32869081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa370
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料